Advertisement
Review Article| Volume 102, ISSUE 3, P365-391, June 2022

Evaluation and Interventional Management of Cardiac Dysrhythmias

Published:April 21, 2022DOI:https://doi.org/10.1016/j.suc.2022.01.003

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Surgical Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Calkins H.
        • Hindricks G.
        • Cappato R.
        • et al.
        2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.
        Heart Rhythm. 2017; 14: e275-e444
        • Hindricks G.
        • Potpara T.
        • Dagres N.
        • et al.
        2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS).
        Eur Heart J. 2020; 42: 373-498
        • Andrade J.G.
        • Aguilar M.
        • Atzema C.
        • et al.
        2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society comprehensive guidelines for the management of atrial fibrillation.
        Can J Cardioliol. 2020; 36: 1847-1948
        • Badwar V.
        • Rankin J.S.
        • Dasmiano R.J.
        • et al.
        The Society of Thoracic Surgeons 2017 clinical practice guidelines for the surgical treatment of atrial fibrillation.
        Ann Thorac Surg. 2017; 103: 329-341
        • January C.T.
        • Wann L.S.
        • Calkins H.
        • et al.
        2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society in collaboration with the Society of Thoracic Surgeons.
        Circulation. 2019; 140: e125-e151
        • Calkins H.
        • Kuck K.H.
        • Cappato R.
        • et al.
        2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design.
        Heart Rhythm. 2012; 9: 632-696
        • Crossley G.H.
        • Poole J.E.
        • Rozner M.A.
        • et al.
        The Heart Rhythm Society (HRS)/American Society of Anesthesiologists (ASA) expert consensus statement on the perioperative management of patients with implantable defibrillators, pacemakers and arrhythmia monitors: facilities and patient management.
        Heart Rhythm. 2011; 9: 1114-1154
        • Kusumoto F.M.
        • Schoenfeld M.H.
        • Wilkoff M.H.
        • et al.
        2007 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction.
        Heart Rhythm. 2017; 14: e503-e551
        • Issa Z.F.
        • Miller J.M.
        • Zipes D.P.
        • et al.
        Atrial fibrillation.
        in: Clinical arrhythmology and electrophysiology. Elsevier, Philadelphia (PA)2019: 433-434
        • Benjamin E.J.
        • Munter P.
        • Alonso A.
        • et al.
        American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2019 update: a report from the American Heart Association.
        Circ. 2019; 139: e56-e528
        • Chung S.S.
        • Havmoeller R.
        • Narayanen K.
        • et al.
        Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study.
        Circ. 2014; 129: 837-847
        • Chung M.K.
        • Refaat M.
        • Shen W.K.
        • et al.
        Atrial fibrillation. JACC council perspectives.
        JACC. 2020; 75: 1689-1713
        • Haissaguerre M.
        • Jais P.
        • Shah D.C.
        • et al.
        Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins.
        N Engl J Med. 1998; 339: 659-666
        • Kazui T.
        • Henn M.C.
        • Watanabe Y.
        • et al.
        The impact of 6 weeks of atrial fibrillation on left atrial and ventricular structure and function.
        J Thorac Cardiovasc Surg. 2015; 150: 1602-1608
        • Kotecha D.
        • Chudasama R.
        • Lane D.A.
        • et al.
        Atrial fibrillation and heart failure due to reduced versus preserved ejection fraction: a systematic review and meta-analysis of death and adverse outcomes.
        Int J Cardiol. 2016; 203: 606-666
        • Ferrari F.
        • Santander I.R.M.F.
        • Stein R.
        Digoxin in atrial fibrillation: an old topic revisited.
        Curr Cardiol Rev. 2020; 16: 141-146
        • Shah M.S.
        • Tsadok M.A.
        • Jackevicius C.A.
        • et al.
        Relation of digoxin use in atrial fibrillation and the risk of all-cause mortality in patients > 65 years of age with versus without heart failure.
        Am J Cardiol. 2014; 114: 401-406
        • Van Gelder I.C.
        • Groenveld H.F.
        • Crijins H.J.
        • et al.
        RACE II Investigators. Lenient versus strict rate control in patients with atrial fibrillation.
        N Engl J Med. 2010; 362: 1363-1373
        • Van Gelder I.C.
        • Hagens V.E.
        • Bosker H.A.
        • et al.
        Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation.
        N Engl J Med. 2002; 347: 1834-1840
        • Roy D.
        • Talajic M.
        • Nattel S.
        • et al.
        Atrial Fibrillation and Congestive Heart Failure Investigators. Rhythm control versus rate control for atrial fibrillation and heart failure.
        N Engl J Med. 2008; 358: 2667-2677
        • Hagens V.E.
        • Ranchor A.V.
        • Van Sonderen E.
        • et al.
        RACE Study Group. Effective of rate or rhythm control on quality of life in persistent atrial fibrillation: results from the Rate Control versus Electrical Cardioversion (RACE) Study.
        J Am Coll Cardiol. 2004; 43: 241-247
        • Kelly J.P.
        • DeVore A.D.
        • Wu J.
        • et al.
        Rhythm control versus rate control in patients with atrial fibrillation and heart failure with preserved ejection fraction: insights from Get with the Guidelines-Heart Failure.
        J Am Heart Assoc. 2019; 8: e011560
        • Lowres N.
        • Mulcahy G.
        • Jin K.
        • et al.
        Incidence of postoperative atrial fibrillation recurrence in patients discharged in sinus rhythm after cardiac surgery: a systematic review and meta-analysis.
        Interact Cardiovasc Thorac Surg. 2018; 26: 504-511
        • Dobrev D.
        • Aguilar M.
        • Heijman J.
        • et al.
        Postoperative atrial fibrillation: mechanisms, manifestations and management.
        Nat Rev Cardiol. 2019; 16: 417-436
        • Echahidi N.
        • Pibarot P.
        • O’Hara G.
        • et al.
        Mechanisms, prevention, and treatment of atrial fibrillation after cardiac surgery.
        J Am Coll Cardiol. 2008; 51: 793-801
        • Gillinov A.M.
        • Bagiella E.
        • Moskowitz A.J.
        • et al.
        Rate control versus rhythm control for atrial fibrillation after cardiac surgery.
        NEJM. 2016; 374: 1911-1921
        • Amar D.
        Postthoracotomy atrial fibrillation.
        Curr Opin Anaesthesiol. 2007; 20: 43-47
        • Philip I.
        • Berroeta C.
        • Leblanc I.
        Perioperative challenges of atrial fibrillation.
        Curr Opin Anaesthesiol. 2014; 27: 344-352
        • Lin M.H.
        • Kamel H.
        • Singer D.E.
        • et al.
        Perioperative/postoperative atrial fibrillation and risk of subsequent stroke and/or mortality.
        Stroke. 2019; 50: 1364-1371
        • AlTurki A.
        • Marafi M.
        • Proietti R.
        • et al.
        Major adverse cardiovascular events associated with postoperative atrial fibrillation after noncardiac surgery: a systematic review and meta-analysis.
        Circ Arrhythm Electrophysiol. 2020; 13: e007437
        • Mathew J.P.
        • Fontes M.L.
        • Tudor I.C.
        • et al.
        Investigators of the Ischemia Research and Education Foundation, Multicenter Study of Perioperative Ischemia Research Group. A multicenter risk index for atrial fibrillation after cardiac surgery.
        JAMA. 2004; 291: 1720-1729
        • Villareal R.P.
        • Hariharan R.
        • Liu B.C.
        • et al.
        Postoperative atrial fibrillation and mortality after coronary artery bypass surgery.
        J Am Coll Cardiol. 2004; 43: 742-748
        • Lee S.H.
        • Kang D.R.
        • Uhm J.S.
        • et al.
        New-onset atrial fibrillation predicts long-term newly developed atrial fibrillation after coronary artery bypass graft.
        Am Heart J. 2014; 167: 593-600
        • Konstantino Y.
        • Zelnik Yovel D.
        • Friger M.D.
        • et al.
        Postoperative atrial fibrillation following coronary artery bypass graft surgery predicts long-term atrial fibrillation and stroke.
        Isr Med Assoc J. 2016; 18: 744-748
        • Cardinale D.
        • Sandri M.T.
        • Colombo A.
        • et al.
        Prevention of atrial fibrillation in high-risk patients undergoing lung cancer surgery: the PRESAGE Trial.
        Ann Surg. 2016; 264: 244-251
        • Ojima T.
        • Nakamori M.
        • Nakamura M.
        • et al.
        Randomized clinical trial of landiolol hydrochloride for the prevention of atrial fibrillation and postoperative complications after oesophagectomy for cancer.
        Br J Surg. 2017; 104: 1003-1009
        • Arsenault K.A.
        • Yusuf A.M.
        • Crystal E.
        • et al.
        Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery.
        Cochrane Database Syst Rev. 2013; : CD003611
        • Ozaydin M.
        • Icli A.
        • Yucel H.
        • et al.
        Metoprolol vs. carvedilol or carvedilol plus N-acetyl cysteine on post-operative atrial fibrillation: a randomized, double-blind, placebo-controlled study.
        Eur Heart J. 2013; 34: 597-604
        • O’Neal J.B.
        • Billings 4th, F.T.
        • Liu X.
        • et al.
        Effect of preoperative beta-blocker use on outcomes following cardiac surgery.
        Am J Cardiol. 2017; 120: 1293-1297
        • Zhu J.
        • Wang C.
        • Gao D.
        • et al.
        Meta-analysis of amiodarone versus beta-blocker as a prophylactic therapy against atrial fibrillation following cardiac surgery.
        Intern Med J. 2012; 42: 1078_1087
        • Auer J.
        • Weber T.
        • Berent R.
        • et al.
        Study of Prevention of Postoperative Atrial Fibrillation. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SPPAF), a randomized, placebo-controlled trial.
        Am Heart J. 2004; 147: 636-643
        • Imazio M.
        • Brucato A.
        • Ferrazzi P.
        • et al.
        Colchicine for prevention of postpericardiotomy syndrome and postoperative atrial fibrillation: the COPPS-2 randomized clinical trial.
        JAMA. 2014; 312: 1016-1023
        • Benjamin E.J.
        • Wolf P.A.
        • D’Agostino R.B.
        • et al.
        Impact of atrial fibrillation on the risk of death: the Framingham Heart Study.
        Circ. 1998; 98: 946-952
        • Lin H.J.
        • Wolf P.A.
        • Kelly-Hayes M.
        • et al.
        Stroke severity and atrial fibrillation. The Framingham Study.
        Stroke. 1996; 27: 1760-1764
        • Ferro J.M.
        Cardioembolic stroke: an update.
        Lancet Neurol. 2003; 2: 177-188
      1. Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation.
        NEJM. 1990; 323: 1505-1511
        • Ezekowitz M.D.
        • Bridgers S.L.
        • James K.E.
        • et al.
        Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs stroke prevention in nonrheumatic atrial fibrillation investigators.
        NEJM. 1992; 327: 1406-1412
        • Connoly S.J.
        • Laupacis A.
        • Gent M.
        • et al.
        Canadian atrial fibrillation anticoagulation (CAF A) study.
        J Am Coll Cardiol. 1991; 18: 349-355
        • Gage B.F.
        • Waterman A.D.
        • Shannon W.
        • et al.
        Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation.
        JAMA. 2001; 285: 2864-2870
        • Lip G.Y.H.
        • Nieuwloat R.
        • Pistero R.
        • et al.
        Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euroheart Survey on Atrial Fibrillation.
        Chest. 2010; 137: 263-272
      2. Atrial fibrillation investigators. Echocardiographic predictors of stroke in patients with atrial fibrillation: a prospective study of 1066 patients from 3 clinical trials.
        Arch Intern Med. 1998; 185: 1316-1320
        • Dibiase L.
        • Santangell P.
        • Anselmimo M.
        • et al.
        Does the left atrial morphology correlate with risk of stroke in patients with atrial fibrillation? Results from a multicenter study.
        J Am Coll Cardiol. 2012; 60: 535-538
        • Zabalgoita M.
        • Halpern J.L.
        • Pearce L.A.
        • et al.
        Stroke Prevention in Atrial Fibrillation III Investigators. Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation.
        J Am Coll Cardiol. 1998; 31: 1622-1626
        • Seeno K.
        • Proletti M.
        • Lane D.A.
        • et al.
        Evaluation of the HAS-BLED, ATRIA, and ORBIT bleeding risk scores in patients with atrial fibrillation taking warfarin.
        AM J Med. 2016; 129: 600-607
        • Albers G.W.
        • Dalen J.E.
        • Lauparis A.
        • et al.
        Antithrombotic therapy in atrial fibrillation.
        Chest. 2001; 119: 194S-206S
        • Connoly S.J.
        • Ezekowitz M.D.
        • Yusuf S.
        • et al.
        Dabigatran versus warfarin in patients with atrial fibrillation.
        NEJM. 2009; 301: 1139-1151
        • Patel M.R.
        • Mahaffey K.W.
        • Garg J.
        • et al.
        Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.
        NEJM. 2011; 365: 883-891
        • Granger C.B.
        • Alexander J.H.
        • McMurray J.J.V.
        • et al.
        Apixaban versus warfarin in patients with atrial fibrillation.
        NEJM. 2011; 365: 981-992
        • Giugliano R.P.
        • Ruff C.T.
        • Braunwald E.
        • et al.
        Edoxaban versus warfarin in patients with atrial fibrillation.
        NEJM. 2013; 369: 2093-2104
        • Doukatis J.D.
        • Spyropoulas A.C.
        • Kaatz S.
        • et al.
        Bridge investigators. Perioperative bridging anticoagulation in patients with atrial fibrillation.
        NEJM. 2015; 373: 823-833
        • Ayoub K.
        • Nairooz R.
        • Almomani A.
        • et al.
        Perioperative heparin bridging in atrial fibrillation patients requiring temporary interruption of anticoagulation. Evidence from meta-analysis.
        J Stroke Cerebrovasc Dis. 2016; 25: 2215-2221
        • Steffel J.
        • Verkamme P.
        • Potpara T.S.
        • et al.
        The 2018 European Heart Rhythm Association practical guide on the use of a non-vitamin K antagonist oral anticoagulation in patients with atrial fibrillation: executive summary.
        Europace. 2018; 20: 1231-1242
        • Connoly S.
        • Crowther M.
        • Eikenboom J.W.
        • et al.
        Full study report of Andexanet alpha for bleeding associated with factor Xa inhibitors.
        NEJM. 2009; 380: 1326-1335
        • Levy J.H.
        • Doukatis J.
        • Weitz J.I.
        • et al.
        Reversal agents for non-vitamin K antagonist oral anticoagulation.
        Nat Rev Cardiol. 2019; 15: 273-281
        • Blackshear J.L.
        • Odell J.A.
        Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation.
        Ann Thorac Surg. 1996; 61: 755-759
        • Sharma S.
        • Devine W.
        • Anderson R.H.
        • et al.
        The determination of atrial arrangement by examination of appendage morphology in 1842 heart specimens.
        Br Heart J. 1988; 60: 227-231
        • Cabrera J.A.
        • Saremi F.
        • Sanchez-Quintana D.
        Left atrial appendage: anatomy and imaging landmarks pertinent to percutaneous transcatheter occlusion.
        Heart. 2014; 100: 1636
        • Wang Y.
        • Dibiase L.
        • Horton R.P.
        • et al.
        left atrial appendage studied by computed tomography to help planning for appendage closure device placement.
        J Cardiovasc Electrophysiol. 2010; 21: 973-982
        • Yaghi S.
        • Chang A.
        • Akiki R.
        • et al.
        The left atrial appendage morphology is associated with embolic stroke subtypes using a simple classification system: a proof of concept study.
        J Cardiovasc Comput Tomography. 2020; 14: 27-33
        • Murtaza G.
        • Turazam M.K.
        • Della Rocca D.G.
        • et al.
        Risks and benefits of removal of the left atrial appendage.
        Curr Cardiol Rep. 2020; 22: 129
        • Dibiase L.
        • Burkhardt J.D.
        • Mohantz P.
        • et al.
        Left atrial appendage: an underrecognized trigger site of atrial fibrillation.
        Circ. 2010; 122: 109-118
        • Friedman D.J.
        • Black-Maier E.W.
        • Barnett A.S.
        • et al.
        Left atrial appendage electrical isolation for treatment of recurrent atrial fibrillation: a meta-analysis.
        JACC Clin Electrophysiol. 2014; 4: 112-120
        • Lakireddy D.
        • Sridhar Maharkali A.
        • Kanmarthareddy A.
        • et al.
        Left atrial appendage ligation and ablation for persistent atrial fibrillation: the LAA LA-AF registry.
        JACC Clin Electrophysiol. 2015; 1: 153-160
        • Edgerton J.R.
        Current state of surgical left atrial appendage exclusion: how and when.
        Card Electrophysiol Clin. 2020; 12: 109-155
        • Reddy V.Y.
        • Sievert H.
        • Halperin J.
        • et al.
        Percutaneous left atrial appendage closure versus warfarin for atrial fibrillation: a randomized clinical trial.
        JAMA. 2014; 32: 1988-1998
        • Reddy V.Y.
        • Doshi S.K.
        • Kar S.
        • et al.
        5-year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT-AF trials.
        JACC. 2017; 70: 2964-2975
        • Salzberg S.P.
        • Plass A.
        • Emmert M.Y.
        • et al.
        Left atrial appendage clip occlusion: early clinical results.
        J Thorac Cardiovasc Surg. 2010; 139: 1269-1274
        • Ailawadi G.
        • Gerdisch M.W.
        • Harvey R.L.
        • et al.
        Exclusion of left atrial appendage with a novel device: early results of a multicenter trial.
        J Thorac Cardiovasc Surg. 2011; 142: 102-109
        • Caliskan E.
        • Cox J.L.
        • Holmes D.R.
        • et al.
        Interventional and surgical occlusion of the left atrial appendage.
        Nat Rev Cardiol. 2017; 14: 727-743
        • Hahalati A.
        • Biancari F.
        • Nielson J.C.
        • et al.
        Radiofrequency ablation versus antiarrhythmic drug therapy as first-line treatment of symptomatic atrial fibrillation: systematic review and meta-analysis.
        Europace. 2015; 17: 370-378
        • Asad Z.A.
        • Yausif A.
        • Khan M.S.
        • et al.
        Catheter ablation versus medical therapy for atrial fibrillation: a systematic review and meta-analysis of early clinical trials.
        Circ Arrhythm Electrophysiol. 2019; 12: e007414
        • Patel N.
        • Patel K.
        • Shenoy A.
        • et al.
        Cryoablation for the treatment of atrial fibrillation: a meta-analysis.
        Curr Cardiolrev. 2019; 15: 230-238
        • Murray M.
        • Arnold A.
        • Youn is M.
        • et al.
        Cryoballoon versus radiofrequency ablation for paroxysmal atrial ablation: a meta-analysis of randomized controlled trials.
        Clin Res Cardiol. 2018; 107: 658-669
        • Chen Y.H.
        • Lu Z.Y.
        • Xiang Y.
        • et al.
        Cryoablation versus radiofrequency ablation for treatment of paroxysmal atrial fibrillation: a systematic review and meta-analysis.
        Europace. 2017; 19: 784-794
        • Kuck K.H.
        • Brugada J.
        • Furnkranz A.
        • et al.
        On behalf of the FIR ED and ICE investigators. Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation.
        NEJM. 2016; 324: 2235-2245
        • Luik A.
        • Radzewitz A.
        • Kieser M.
        • et al.
        Cryoballoon versus open irrigated radiofrequency ablation in patients with paroxysmal atrial fibrillation: the prospective randomized, controlled, noninferiority FREEZE AF study.
        Circ. 2015; 132: 1311-1319
        • Vogt J.
        • Heintze J.
        • Gutleben K.J.
        • et al.
        Long-term outcomes after cryoballoon pulmonary vein isolation: results from a prospective study in 605 patients.
        JACC. 2013; 61: 1707-1712
        • Gupta A.
        • Perera T.
        • Ganesan A.
        • et al.
        Complications of catheter ablation of atrial fibrillation: a systematic review.
        Circ arrhythmia Electrophysiol. 2013; 6: 1082-1088
        • Parameswaran R.
        • Al-Kaisez A.M.
        • Kalman J.M.
        • et al.
        Catheter ablation for atrial fibrillation: current indications and evolving technologies.
        Nat Rev Cardiol. 2021; 18: 210-225
        • Cox J.L.
        • Boineau J.P.
        • Schessler R.B.
        • et al.
        Successful surgical treatment of atrial fibrillation. Review and clinical update.
        JAMA. 1991; 266: 1976-1980
        • Cox J.L.
        • Schessler R.B.
        • Lappas D.G.
        • et al.
        An 8-1/2-year clinical experience with surgery for atrial fibrillation.
        Ann Surg. 1996; 224 (2008; 85: 909-275): 267-275
        • Gaynor S.L.
        • Diodato M.D.
        • Prassad S.M.
        • et al.
        A prospective single-center clinical trial of a modified Cox maze procedure with bipolar radiofrequency ablation.
        J Cardiovasc Thorac Surg. 2004; 128: 535-542
        • Mokadam N.A.
        • McCarthy P.M.
        • Gillinov A.M.
        • et al.
        A prospective multicenter trial of bipolar radiofrequency ablation for atrial fibrillation: early results.
        Ann Thorac Surg. 2004; 78: 1665-1670
        • Damiano R.J.
        • Schwartz F.H.
        • Bailey M.S.
        • et al.
        the Cox-Maze for procedure: predictors of late recurrence.
        J Cardiovasc Thorac Surg. 2011; 141: 113-121
        • Cheema F.H.
        • Younus M.J.
        • Pasha A.
        • et al.
        effective modification to simplify the right atrial lesion set of the Cox-cryomaze.
        Ann Thorac Surg. 2013; 96: 330-332
        • Lawrence C.P.
        • Hen M.C.
        • Miller J.R.
        • et al.
        A minimally base of Cox-Maze for procedure is as effective as sternotomy while decreasing major morbidity and hospital stay.
        J Cardiovasc Thorac Surg. 2014; 148: 955-962
        • Gammie J.S.
        • Haddad M.
        • Milford-Beland S.
        • et al.
        Atrial fibrillation corrective surgery: lessons from the Society of Thoracic Surgery National Cardiac Database.
        Ann Thorac Surg. 2008; 85: 909-914
        • Badhwar V.
        • Rankin J.S.
        • Ad N
        • et al.
        Surgical ablation of atrial fibrillation in the United States: trends and propensity matched outcomes.
        Ann Thorac Surg. 2017; 104: 493-500
        • Barrett S.D.
        • Ad N.
        Surgical ablation as treatment for the elimination of atrial fibrillation: a meta-analysis.
        J Cardiovasc Thorac Surg. 2006; 131: 1029-1035
        • Melo J.
        • Santiago T.
        • Aguiar C.
        • et al.
        Surgery for atrial fibrillation in patients with mitral valve disease: results at 5 years from the international registry of atrial fibrillation surgery.
        J Cardiovasc Thorac Surg. 2008; 135: 863-869
        • Saint L.L.
        • Damiano R.J.
        • Cuculich P.S.
        • et al.
        Incremental risk of the Cox-Maze IV procedure for patients with atrial fibrillation undergoing mitral valve surgery.
        J Cardiovasc Thorac Surg. 2013; 146: 1072-1077
        • Edgerton J.R.
        • Jackman W.M.
        • Mack M.J.
        A new epicardial lesion set for minimal access left atrial maze: the dialysis lesion set.
        Ann Thorac Surg. 2009; 88: 1655-1657
        • Edgerton J.R.
        • Jackman W.M.
        • Mahoney
        • et al.
        Totally thoracoscopic surgical ablation of persistent AF and longstanding persistent atrial fibrillation using the "Dallas" lesion set.
        Heart Rhythm. 2009; 6: S64-S70
        • Lockwood D.
        • Nakagawa H.
        • Peyton M.D.
        • et al.
        Linear left atrial lesions in minimally invasive surgical ablation of persistent atrial fibrillation: techniques for assessing conduction block across surgical lesions.
        Heart Rhythm. 2009; 6: S50-S63
        • Gillinov A.M.
        • Gelijns A.C.
        • Paraides M.K.
        • et al.
        Surgical ablation of atrial fibrillation during mitral-valve surgery.
        N Engl J Med. 2015; 372: 1399-1409
        • Rankin J.S.
        • He X.
        • O-Brien S.M.
        • et al.
        The Society of Thoracic Surgeons risk model for operative mortality after multiple valve surgery.
        Ann Thorac Surg. 2013; 95: 1484-1490
        • Malaisrie S.C.
        • Lee R.
        • Kruse J.
        • et al.
        Atrial fibrillation ablation in patients undergoing aortic valve replacement.
        J Heart Valve Dis. 2012; 21: 350-357
        • Cherniavsky A.
        • Kareva Y.
        • Pak I.
        • et al.
        Assessment of results of surgical treatment for persistent atrial fibrillation during coronary artery bypass grafting using implantable loop recorders.
        Interact Cardiovasc Thorac Surg. 2014; 18: 727-731
        • Yoo J.S.
        • Kim J.B.
        • Ro S.K.
        • et al.
        Impact of concomitant surgical atrial fibrillation ablation in patients undergoing aortic valve replacement.
        Circ J. 2014; 78: 1364-1371
        • LaMeir M.
        New technologies and hybrid surgery for atrial fibrillation.
        Ramdan Maimonides Med J. 2013; 4: 1-8
        • Richardson T.D.
        • Shoemaker M.B.
        • Whalen S.P.
        • et al.
        Staged versus simultaneous thoracoscopic hybrid ablation for persistent atrial fibrillation does not affect time to recurrence of atrial arrhythmia.
        J Cardiovasc Electrophysiol. 2016; 27: 428-434
        • Salzberg S.P.
        • Zerm J.
        • Wyss C.
        • et al.
        AF Heart Team” guided indication for stand-alone thoracoscopic left atrial appendage ablation and left atrial appendage closure..
        J Atrial Fib. 2019; 1: 1-7
        • Vos L.M.
        • Bentala M.
        • Geruzebrock G.S.C.
        • et al.
        Long-term outcome after totally thoracoscopic ablation for atrial fibrillation.
        J Cardiovasc Electrophysiol. 2020; 31: 40-45
        • Ni B.
        • Wang Z.
        • Gu W.
        • et al.
        Thoracoscopic left atrial appendage exclusion plus ablation for atrial fibrillation to prevent stroke.
        Semin Throrac Surg. 2020; 33: 61-67
        • Maesen B.
        • Pison L.
        • Vroomen M.
        • et al.
        Three-year follow-up of hybrid ablation for atrial fibrillation.
        Eur J Cardiothorac Surg. 2018; 53: 26-32
        • Van Laar C.
        • Kelder J.
        • vanPutte B.P.
        The totally thoracoscopic Maze procedure for the treatment of atrial fibrillation.
        Interact Cardiovasc Thorac Surg. 2017; 24: 102-111
        • Phan K.
        • Pison L.
        • Wang N.
        • et al.
        Effectiveness and safety of simultaneous hybrid thoracoscopic and endocardial catheter ablation of atrial fibrillation in the obese and nonobese patient.
        J Thorac Dis. 2017; 9: 3087-3096
        • Kim H.R.
        • Joeng D.S.
        • Kwon H.J.
        • et al.
        Totally thoracoscopic ablation in patients with atrial fibrillation and left ventricular dysfunction.
        JTCVS Tech. 2021; 20: 60-66
        • deAsmundis C.
        • Varnavas V.
        • Siera J.
        • et al.
        2-year follow-up of a 1 stage left unilateral thoracoscopic epicardial and transcatheter endocardial ablation for persistent and longstanding persistent atrial fibrillation.
        J Interv Card Electrophysiol. 2020; 50: 333-343
        • Yi S.
        • Lu X.
        • Wang W.
        • et al.
        Thoracoscopic surgical ablation or catheter ablation for patients with atrial fibrillation? A systematic review and meta-analysis of randomized control trials.
        Interact Cardiovasc Thorac Surg. 2020; 31: 763-773
        • Wang T.K.M.
        • Liao Y.W.
        • Wamg M.T.M.
        • et al.
        Catheter vs thoracoscopic ablation for atrial fibrillation: meta-analysis of randomized trials.
        J Arrhythmia. 2020; 36: 789-793
        • Haldar S.
        • Khan H.R.
        • Boyalla V.
        • et al.
        Catheter ablation versus thoracoscopic surgery ablation and long stay persistent atrial fibrillation: CASA-AF randomized control trial.
        Eur Heart J. 2020; 41: 4471-4480
        • Castella M.
        • Kotacha D.
        • van Laar C.
        • et al.
        Thoracoscopic versus catheter ablation for atrial fibrillation: long-term follow-up of the F AST randomized trial.
        Europace. 2019; 21: 746-753
        • Phan K.
        • Phan S.
        • Thiagalingam A.
        • et al.
        Thoracoscopic surgical ablation versus catheter ablation for atrial fibrillation.
        Eur J Cardiothorac Surg. 2016; 49: 1044-1051
        • Gehi A.K.
        • Mounsey J.P.
        • Pursell I.
        • et al.
        Hybrid epicardial-endocardial ablation using a pericardioscopic technique for the treatment of atrial fibrillation.
        Heart Rhythm. 2013; 10: 22-28
        • Gersak B.
        • Pernat A.
        • Robic B.
        • et al.
        Low rate of atrial fibrillation recurrence verified by implantable loop recorder monitoring following a convergent epicardial and endocardial ablation of atrial fibrillation.
        J Cardiovasc Electrophysiol. 2012; 23: 1059-1066
        • Maclean E.
        • Yap J.
        • Saberwal B.
        • et al.
        The convergent procedure versus catheter ablation alone in longstanding persistent atrial fibrillation: a single center, propensity-matched cohort study.
        Int J Cardiol. 2020; 303: 49-53
        • Ellis C.R.
        • Badhwar N.
        • Tschopp D.
        • et al.
        Subxiphoid hybrid epicardial-endocardial atrial fibrillation ablation and LAA ligation: initial Sub-X Hybrid Maze Registry results.
        JACC Clin Electrophysiol. 2020; 6: 1603-1615
        • De Lurgio D.B.
        • Crossen K.J.
        • Gill J.
        • et al.
        Hybrid convergent procedure for the treatment of persistent and longstanding persistent atrial fibrillation: results of the CONVERGE clinical trial.
        Circ Arrhythm Electrophysiol. 2020; 13: e009288
        • Mulpuru S.K.
        • Madhaven M.
        • McLeod C.J.
        • et al.
        Cardiac pacemakers: function, troubleshooting, and management.
        JACC. 2017; 69: 211-235
        • Kadish A.
        • Dyer A.
        • Daubert J.P.
        • et al.
        Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy.
        N Eng J Med. 2004; 350: 2151-2158
        • Moss A.J.
        • Zareba W.
        • Hall W.J.
        • et al.
        Prophylactic implantation of a defibrillator in patients with a myocardial infarction and reduced ejection fraction.
        N Eng J Med. 2002; 346: 877-883
        • Bardy G.H.
        • Lee K.L.
        • Mark D.B.
        • et al.
        Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.
        N Eng J Med. 2005; 352: 225-237
        • Rozner M.A.
        Cardiac implantable electrical devices.
        in: Kaplan J.A. Kaplan's cardiac anesthesia: for cardiac and noncardiac surgery. Elsevier, Philadelphia (PA)2016: 1663
        • Brugada P.
        • Geelen P.
        Some electrocardiographic patterns predicting sudden cardiac death that every doctor should recognize.
        Acta Cardiol. 1997; 52: 473-484
        • Maron B.J.
        • Shen W.K.
        • Link M.S.
        • et al.
        Efficacy of implantable cardio converter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy.
        N Eng J Med. 2000; 342: 365-373
        • Katbeh A.
        • Van Camp G.
        • Barbato E.
        • et al.
        Cardiac resynchronization therapy optimization: a comprehensive approach.
        Cardiology. 2019; 142: 116-127
        • American Society of Anesthesiologists
        Practice advisory for the perioperative management of patients with cardiac implantable electronic devices: pacemakers and implantable cardioverter-defibrillators: an update report by the American Society of Anesthesiologists Task Force on Perioperative Management of Patients with Cardiac Implantable Electronic Devices.
        Anesthesiology. 2011; 114: 247-261
        • Lindsey B.D.
        • Estes III, N.A.
        • Maloney J.D.
        • et al.
        Heart Rhythm Society policy statement update: recommendations on the role of Industry Employed Allied Professionals (IEAPs).
        Heart Rhythm. 2008; 5: 8-10
        • Cronin B.
        • Essandoh M.K.
        Perioperative interrogation of St Jude cardiovascular implantable electronic devices: a guide for anesthesiologists.
        J Cardiothorac Vasc Anesth. 2018; 32: 982-1000
        • Cronin B.
        • Birghersdotter U.
        • Essandoh M.K.
        Perioperative interrogation of Boston Scientific cardiovascular implantable electronic devices: a guide for anesthesiologists.
        J Cardiothorac Vasc Anesth. 2019; 33: 1076-1089
        • Cronin B.
        • Dalia A.
        • Sandoval K.
        • et al.
        Perioperative interrogation of Biotronik cardiovascular implantable electronic devices: a guide for anesthesiologists.
        J Cardiothorac Vasc Anesth. 2019; 33: 3427-3436
        • Cronin B.
        • Dalia A.
        • Hguyen Q.S.
        • et al.
        Perioperative interrogation of Medtronic cardiovascular implantable electronic devices: a guide for anesthesiologists.
        J Cardiothorac Vasc Anesth. 2020; 34: 2465-2475
        • Cronin B.
        • Essadoh M.K.
        Update on cardiovascular implantable electronic devices for anesthesiologists.
        J Cardiothorac Vasc Anesth. 2018; 32: 1871-1884
        • Hesselson A.B.
        A simple technique for relocating chronic CI ED leads to a subpectoral position for relief of erosion and pain.
        Pacing Clin Electrophysiol. 2018; 41: 834-838
        • Pokorney S.D.
        • Mi X.
        • Lewis R.K.
        • et al.
        Outcomes associated with extraction versus capping and abandoning pacing and defibrillator leads.
        Circulation. 2017; 136: 1387-1395
        • Boyle T.A.
        • Uslan D.Z.
        • Prutkin J.M.
        • et al.
        Impact of abandoned leads on cardiovascular implantable electronic device infections: a propensity matched analysis of MEDIC (multicenter electrophysiologic device infection cohort).
        JACC Clin Electrophysiol. 2018; 4: 209-211
        • Wilkoff B.L.
        • Love C.J.
        • Byrd G.H.
        • et al.
        transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management.
        Heart Rhythm. 2009; 6: 1085-1104
        • Carrillo R.G.
        • Tsang D.C.
        • Azarafiy R.
        • et al.
        Multi-year evaluation of compliant endovascular balloon in treating superior vena cava tears during transvenous lead extraction EHRA late breaking trial.
        March. 2018; 19
        • Okamura H.
        Lead extraction using a laser system: techniques, efficacy, and limitations.
        J Arrhythmia. 2016; 32: 279-282
      3. Wazni, O, Epstein LM, Carrillo RG, et al. Lead extraction in the contemporary setting: the Lexicon study: a multicenter observational retrospective study of consecutive laser lead extractions, JACC 55: 579-586.

        • Kusumoto F.M.
        • Schoenfeld M.H.
        • Wilkoff B.L.
        2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction.
        Heart Rhythm. 2017; 14: e503-e551
        • Bashir J.
        • Carrillo R.G.
        Cardiac and vascular injury sustained during transvenous lead extraction.
        Card Electrophysiol Clin. 2018; 10: 651-657